Frankfurt - Delayed Quote EUR
Diamyd Medical AB (publ) (DMN.F)
0.9040
+0.0370
+(4.27%)
As of 9:16:24 AM GMT+2. Market Open.
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | -- | -- | -- | 233M |
| Low Estimate | -- | -- | -- | 233M |
| High Estimate | -- | -- | -- | 233M |
| Year Ago Sales | -- | -- | 4.36M | -- |
| Sales Growth (year/est) | -- | -- | -100.00% | 0.00% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| DMN.F | -- | -- | -- | -- |
| S&P 500 | 13.13% | 2.46% | 7.55% | 14.08% |
Related Tickers
EGTX.ST Egetis Therapeutics AB (publ)
4.3100
+1.41%
ARDS Aridis Pharmaceuticals, Inc.
0.0001
0.00%
CSBR Champions Oncology, Inc.
6.60
-4.21%
HNSA.ST Hansa Biopharma AB (publ)
25.58
-0.08%
LIPO Lipella Pharmaceuticals Inc.
2.9100
-2.68%
WVE Wave Life Sciences Ltd.
7.05
-2.35%
AVCT.L Avacta Group Plc
33.40
+1.21%
JSPR Jasper Therapeutics, Inc.
5.94
-1.16%
ONCO Onconetix, Inc.
0.0797
+7.56%
SNPX Synaptogenix, Inc.
3.4800
+44.40%